Evaluation of antimycobacterial activity of a sulphonamide derivative

Tuberculosis

Volumn 93, Issue 3, 2013, Pages 318-321

  Agertt, Vanessa Albertina ^a   Marques, Lenice Lorenço ^a   Bonez, Pauline Cordenonsi ^a   Dalmolin, Tanise Vendruscolo ^a   Manzoni De Oliveira, Gelson Noe ^a   De Campos, Marli Matiko Anraku ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antimycobacterial actives; Mycobacterium smegmatis; Sulfonamides; Trimethoprim

Indexed keywords

ANTIMYCOBACTERIAL AGENT; ISONIAZID; RIFAMPICIN; SULFAMETHOXAZOLE; SULFONAMIDE; TRIMETHOPRIM;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SCREENING; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM SMEGMATIS; SULFONAMIDES; TRIMETHOPRIM;

EID: 84875810086     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.02.003     Document Type: Article

References (24)

1. World Health Organization Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response 2010 World Health Organization Geneva, Switzerland
2. World Health Organization WHO report 2009: global tuberculosis control: epidemiology, strategy, financing 2009 World Health Organization Geneva, Switzerland
3. C.D. Mitnikc, B. McGee, and C.A. Peloquin Tuberculosis pharmacotherapy: strategies to optimize patient care Expert Opin Pharmacother 10 3 2009 381 401
4. S.C. Resch, J.A. Salomon, M. Murray, and M.C. Weinstein Cost-effectiveness of treating multidrug-resistant tuberculosis PLoS Med 3 7 2006 1048 1057
5. J.A. Salomon, J.O. Lloyd-Smith, W.M. Getz, S. Resch, M.S. Sánchez, T.C. Porco, and M.W. Borgdorff Prospects for advancing tuberculosis control efforts through novel therapies PLoS Med 3 8 2006 1302 1309
6. H. Wagner, and G. Ulrich-Merzenich Synergy: approaching a new generation of phitopharmaceuticals Phytomedicine 16 2009 97 110
7. A. De Logu, V. Onnis, B. Saddi, C. Congiu, M.L. Schivo, and M.T. Cocco Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniasid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis J Antimicrob Chemother 49 2002 275 282
8. P.A. Masters, T.A. O'Bryan, J. Zurlo, D.Q. Miller, and N. Joshi Trimethoprim-sulfamethoxazole revisited Arch Intern Med 163 2003 402 410
9. P. Forgacs, N.L. Wengenack, L. Hall, S.K. Zimmerman, M.L. Silverman, and G.D. Roberts Tuberculosis and trimethoprim-sulfamethoxazole Antimicrob Agents Chemother 53 11 2009 4789 4793
10. B.L. Wilkinson, L.F. Bornaghi, A.D. Wright, T.A. Houston, and S.A. Poulsen Anti-mycobacterial activity of a bis-sulfonamide Bioorg Med Chem 17 2007 1355 1357
11. D.J. Owen, C.B. Davis, R.D. Hartnell, P.D. Madge, R.J. Thomson, A.K.J. Chong, R.L. Coppel, and M. von Itzstein Synthesis and evaluation of galactofuranosyl N, N-dialkilsulfenamides and sulfonamides as antimycobacterial agents Bioorg Med Chem 17 2007 2274 2277
12. W.J. Suling, L.E. Seitz, R.C. Reynolds, and W.W. Barrow New mycobacterium aviumantifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors Antimicrob Agents Chemother 49 11 2005 4801 4803
13. W.J. Suling, L.E. Seitz, V. Pathak, L. Westbrook, E.W. Barrow, S. Zywno-Van-Ginkel, R.C. Reynolds, J.B. Piper, and W.W. Barrow Antimycobacterial activities of 2,4-Diamino-5-Ddeazapteridine derivates and effects on mycobacterial dihydrofolato reductase Antimicrob Agents Chemother 44 10 2000 2784 2793
14. M. Cuenca-Estrella Combinations of antifungal agents in therapy: what value are they J Antimicrob Chemother 54 5 2004 854 869
15. L.L. Marques, G.M. Oliveira, E.S. Lang, M.M.A. Campos, and L.R.S. Gris New gold(I) and silver(I) complexes of sulfamethoxazole: synthesis, X-ray structural characterization and microbiological activities of triphenylphosphine (sulfamethoxazolato-N2) gold(I) and (sulfamethoxazolato) silver(I) Inorg Chem Commun 10 2007 1083 1087
16. M.M. Sankar, K. Gopinath, R. Singla, and S. Singh In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay Ann Clin Microbiol Antimicrob 7 15 2008 1 9
17. S.G. Franzblau, R.S. Witzig, J.C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M.T. Degnan, M.B. Cook, V.K. Quenzer, R.M. Fergunson, and R.H. Gilman Rapid low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplatealamar blue assay J Antimicrob Chemother 36 2 1998 362 366
18. NCCLS Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically NCCLS/CLSI document M7-A6 2003 NCCLS Wayne, PA
19. R.N. Mshana, G. Tadesse, G. Abate, and H. Miörner Use of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifanpin-resistant Mycobacterium tuberculosis J Clin Microbiol 36 5 1998 1214 1219
20. D. Lechner, S. Gibbons, and F. Bucar Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis J Antimicrob Chemother 62 2008 345 348
21. A.N. Boucher, and V.H. Tam Mathematical formulation of additivity for antimicrobial agents Diagn Microbiol Infect Dis 55 2006 319 325
22. S.F. vanVuuren, and A.M. Viljoen In vitro evidence of phyto-synergy for plant part combinations of Croton gratissimus (Euphorbiaceae) used in African traditional healing J Ethnopharmacology 119 2008 700 704
23. G.B. Elion, S. Singer, and G.H. Hitchings Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites J Biol Chem 208 1954 477 488
24. S.N. Leonard, G.W. Kaatz, R.L. Rucker, and M.J. Rybac Synergy between gemifloxacin and trimetoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus J Antimicrob Chemother 62 2008 1305 1310